Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 4 1Phase 3 1Phase 1 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Lymphoma 4Breast Neoplasms 4Uterine Cervical Neoplasms 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Ovarian Neoplasms 1Neutropenia 1Multiple Myeloma 1Malignant Solid Tumors 1Lymphoma, Non-Hodgkin 1Hematologic Neoplasms 1Breastcancer 1Bone Neoplasms 1

Interventions

Rituximab 5Cyclophosphamide 3pirtobrutinib 2pegfilgrastim 2Granulocyte Colony-Stimulating Factor 2Filgrastim 2Drug Therapy 2Doxorubicin 2temsirolimus 1plerixafor 1pegylated granulocyte colony-stimulating factor 1ledipasvir, sofosbuvir drug combination 1ibrutinib 1ibritumomab tiuxetan 1fludarabine phosphate 1entecavir 1Vincristine 1Valsartan 1Thiotepa 1Tenofovir 1Sofosbuvir 1Ribavirin 1Radiotherapy 1Prilocaine 1Prednisone 1Oxygen 1Ifosfamide 1Fibroblast Growth Factor 7 1Dexamethasone 1Cytarabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 4 × Lymphoma, Non-Hodgkin × pegylated granulocyte colony-stimulating factor × Clear all
NCT04083079 2019-09-10

Cost-Effectiveness Study of PEG-rhG-CSF in Prophylactic Treatment of Neutropenia After Chemotherapy in Lymphoma

Ruijin Hospital

Phase 4 Unknown
250 enrolled
Lymphoid

Lymphoma, Non-Hodgkin

Data powered by HemOnc (CC BY 4.0) Colophon âš¡